American Association for the Advancement of Science, Science Translational Medicine, 506(11), 2019
DOI: 10.1126/scitranslmed.aav4881
Full text: Unavailable
Rapamycin alleviates β-thalassemia by stimulating ULK1-dependent clearance of toxic free α-globin.